| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 08/05/2004 | US20040152134 Eating disorders; sexual disorders; erectile dysfunction |
| 08/05/2004 | US20040152102 for athersclerosis detection/treatment based on gene expression; genetic engineering |
| 08/05/2004 | US20040152078 Genetic engineering |
| 08/05/2004 | US20040152074 Seroreactive regions on HPV 16 proteins E1 and E2 |
| 08/05/2004 | US20040151789 Herbal compositions for the treatment of mucosal lesions |
| 08/05/2004 | US20040151736 Use of cross-protection to identify novel vaccine candidates for infectious agents |
| 08/05/2004 | US20040151726 Novel vaccine for prophylaxis and theraphy in vetirinary and human medicine |
| 08/05/2004 | US20040151717 Use of polyclonal immunoglobulins |
| 08/05/2004 | US20040151708 Strain of micro-organism lactobacillus fermentum me-3 as novel anti-microbial and anti-oxidative probiotic |
| 08/05/2004 | CA2648056A1 Designed deimmunized monoclonal antibodies for protection against hiv exposure and treatment of hiv infection |
| 08/05/2004 | CA2513881A1 Immunomodulatory compositions |
| 08/05/2004 | CA2513571A1 The use of bacterial phage-associated lysing proteins for preventing and treating bacterial infections in humans, animals and fowl |
| 08/04/2004 | EP1443112A2 Macrophage activating factors derived from cloned vitamin D binding protein |
| 08/04/2004 | EP1443106A1 Somatic cell derived embryonic stem cells and its differentiated cells |
| 08/04/2004 | EP1443054A1 Anitmicrobial proteins, genes encoding the proteins and mehtod of using the same |
| 08/04/2004 | EP1443051A2 Sugar modified oligonucleotides that detect and modulate gene expression |
| 08/04/2004 | EP1443047A1 Novel carbapenem compounds |
| 08/04/2004 | EP1443041A1 5-amidino-2-hydroxybenzenesulfonamide derivatives, medicinal compositions containing the same, medicinal use thereof and intermediates in the production thereof |
| 08/04/2004 | EP1442744A2 Use of EP4 receptor ligands in the treatment of, inter alia, neuropathic pain and colon cancer |
| 08/04/2004 | EP1442143A2 RNA INTERFERENCE MEDIATED INHIBITION OF BCL2 GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 08/04/2004 | EP1442125A2 Chimeric viral vectors for gene therapy |
| 08/04/2004 | EP1442124A1 Polypeptide antigen forming a mimetic structure of the gp41 intermediate state |
| 08/04/2004 | EP1442114A2 Novel bacterial poultry disease |
| 08/04/2004 | EP1442058A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 08/04/2004 | EP1442052A1 High level constitutive production of anthrax protective antigen |
| 08/04/2004 | EP1442050A2 Linear basic compounds having nk-2 antagonist activity and formulations thereof |
| 08/04/2004 | EP1442047A2 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 08/04/2004 | EP1442044A1 A process for the preparation of cefixime via alkyl-or aryl-sulfonates |
| 08/04/2004 | EP1442038A2 Crystalline forms of carbapenem antibiotics and methods of preparation |
| 08/04/2004 | EP1442017A1 Preparation of benzosuberonylpiperidine compounds |
| 08/04/2004 | EP1442008A1 Unsaturated 1-amino-alkylcyclohexane nmda, 5ht3 and neuronal nicotinic receptor antagonists |
| 08/04/2004 | EP1441772A2 Polymer conjugates of protein kinase c inhibitors |
| 08/04/2004 | EP1441769A1 Low concentration of peroxide for treating or preventing vaginal infections |
| 08/04/2004 | EP1441762A1 Rsv gene expression vaccine |
| 08/04/2004 | EP1441761A2 Methods of preventing and treating flavivirus infection in animals |
| 08/04/2004 | EP1441760A2 Anthrax antigenic compositions |
| 08/04/2004 | EP1441755A2 Topical use of cytokines and chemokines for the treatment of viral or mykotic skin diseases or tumoral diseases |
| 08/04/2004 | EP1441754A1 Use of egf to inhibit pathogenic infections of the urogenital tract |
| 08/04/2004 | EP1441744A2 Improvements in or relating to inhibition of viruses |
| 08/04/2004 | EP1441738A1 A combination product comprising melagatran and dexamethasone |
| 08/04/2004 | EP1441735A1 N-substituted hydroxypyrimidinone carboxamide inhibitors of hiv integrase |
| 08/04/2004 | EP1441734A1 Dihydroxypyrimidine carboxamide inhibitors of hiv integrase |
| 08/04/2004 | EP1441730A1 Hydrazono-malonitriles |
| 08/04/2004 | EP1441725A1 Benzimidazoles and analogues and their use as protein kinases inhibitors |
| 08/04/2004 | EP1441720A1 Inhibitors of serine protease, particularly hepatitis c virus ns3-ns4a protease, incorporating a fused ring system |
| 08/04/2004 | EP1441718A2 Carbinols for the treatment of neuropathic dysfunction |
| 08/04/2004 | EP1441715A1 Lipoxins and aspirin-triggered lipoxins and their stable analogs in the treatment of asthma and inflammatory airway diseases |
| 08/04/2004 | EP1441704A1 Orodispersible tablet having high homogeneity and the preparation method thereof |
| 08/04/2004 | EP1441701A1 Montelukast granule formulation |
| 08/04/2004 | EP1441698A1 Flashmelt oral dosage formulation |
| 08/04/2004 | EP1441697A2 Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease |
| 08/04/2004 | EP1401275A4 Antiviral composition and treatment method |
| 08/04/2004 | EP1313772B1 New cross-linked derivatives of hyaluronic acid |
| 08/04/2004 | EP1294380B1 A method for treating septic shock |
| 08/04/2004 | EP1287003B1 Process for preparing a pure, pharmacopoeial grade amorphous form of cefuroxime axetil |
| 08/04/2004 | EP1196155B1 New use of compounds as antibacterial agents |
| 08/04/2004 | EP1165140B1 Adjuvant compositions for enhancing immune responses to polynucleotide-based vaccines |
| 08/04/2004 | EP1150658B1 Method for controlling liposome size |
| 08/04/2004 | EP1140021B1 Improved formulation for topical non-invasive application in vivo |
| 08/04/2004 | EP1129212B1 Screening process for antibacterial agents |
| 08/04/2004 | EP1071745B1 Process for synthesizing cox-2 inhibitors |
| 08/04/2004 | EP0951299B1 Method of producing active immunity with vaccine conjugate |
| 08/04/2004 | EP0950059B1 Cyclic sulfone derivatives |
| 08/04/2004 | EP0934531B1 Diagnosis of spongiform encephalopathy |
| 08/04/2004 | EP0915899B1 Preparation of crystal form ii of clarithromycin |
| 08/04/2004 | EP0637963B1 Cd28 pathway immunoregulation |
| 08/04/2004 | CN1518559A VHH single heavy chain antibody and method for its preparation in mammal |
| 08/04/2004 | CN1518550A Imidazo [1,2-A] pyridine derivatives for prophylaxis and treatment of herpes viral infections |
| 08/04/2004 | CN1518549A Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same |
| 08/04/2004 | CN1518546A Selective anthranilamide pyridine amides as inhibitors of VEGRF-2 and VEGFR-3 |
| 08/04/2004 | CN1518543A Pyrazole derivatives and their use as protein kinase inhibitors |
| 08/04/2004 | CN1518542A Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes |
| 08/04/2004 | CN1518457A Methods of inducing cytotoxic immune response and recombinant simian ademovirus compositions useful therein |
| 08/04/2004 | CN1518456A Capsular polysaccharide solubilisation and combination vaccines |
| 08/04/2004 | CN1518455A Anti-bacterial agent |
| 08/04/2004 | CN1518451A Identifying and treatment of purastic fungi of organism |
| 08/04/2004 | CN1518449A Pediatric formulation of gatifloxacin |
| 08/04/2004 | CN1518447A Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic agents |
| 08/04/2004 | CN1517347A Antivirus nucleoside derivative |
| 08/04/2004 | CN1517326A Capejasmine cycloolefines ether terpene extract and its preparation method and use |
| 08/04/2004 | CN1517124A Chinese medicinal composition possessing antipyretic and its preparation method and quality control method |
| 08/04/2004 | CN1517123A Medicine for treating virus hepatitis and its preparation method |
| 08/04/2004 | CN1517119A Medicinal wine or liquid for treating cold |
| 08/04/2004 | CN1517116A Combined Chinese and western herbal medicine vagina bactericidal agent and its preparation method |
| 08/04/2004 | CN1517112A Chinese medicine for treating pulmonary fuberculosis |
| 08/04/2004 | CN1517108A External-application medicine for treating icterus of liver disease |
| 08/04/2004 | CN1517103A Natural medicine 'keaite capsule' possessing triple effect for treating HIV/AIDS |
| 08/04/2004 | CN1517095A Anti-infection medicine |
| 08/04/2004 | CN1517090A Animal use suspensoid injection or emulsion containing antibacterial medicine |
| 08/04/2004 | CN1517089A Indometacin eyedrops |
| 08/04/2004 | CN1160469C Identification of genes |
| 08/04/2004 | CN1160457C Recombinant mistletoe lectin (rML) |
| 08/04/2004 | CN1160371C NOTCH protein and their ligands |
| 08/04/2004 | CN1160352C Three-site substituted beta-carboline novel compound having anti-HIV and anti-cancer activity, preparation method and its composition and use |
| 08/04/2004 | CN1160343C Aminothiazole inhibitors of cyclin dependent protein kinasses of cells |
| 08/04/2004 | CN1160339C Process for preparing fluconazole as antifungal medicine |
| 08/04/2004 | CN1160128C Antiviral formulations comprising propylene glycol and isopropyl alkanoic acid ester |
| 08/04/2004 | CN1160124C Process for preparing bacterial vaccine for aquiculture animal |
| 08/04/2004 | CN1160123C Use of ulinastatin in treating SARS and medicinal composition thereof |
| 08/04/2004 | CN1160117C Bone-repairing material preparing method |